US Stock MarketDetailed Quotes

MEIP MEI Pharma

Watchlist
  • 3.1000
  • +0.0400+1.31%
Trading Nov 5 10:05 ET
20.65MMarket Cap1.16P/E (TTM)

MEI Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.83%-50.47M
-59.25%-18M
75.86%-2.93M
22.53%-11.06M
-25.09%-18.49M
-7.67%-52.48M
27.10%-11.3M
28.46%-12.13M
-66.59%-14.27M
-91.45%-14.78M
Net income from continuing operations
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
5.06%-16.62M
Operating gains losses
102.90%32K
----
----
----
----
94.68%-1.1M
--0
103.91%500K
91.10%-486K
56.82%-1.12M
Depreciation and amortization
-0.78%383K
27.55%125K
-11.34%86K
-7.61%85K
-12.12%87K
18.40%386K
15.29%98K
8.99%97K
22.67%92K
28.57%99K
Other non cash items
70.26%2.43M
254.37%1.3M
7.22%386K
6.78%378K
6.59%372K
57.21%1.43M
34.07%366K
92.51%360K
--354K
--349K
Change In working capital
-237.82%-84.28M
-506.24%-12.34M
253.04%5.06M
94.84%-1.31M
-8,050.32%-75.69M
-247.83%-24.95M
-294.57%-2.04M
0.21%1.43M
-507.93%-25.3M
-90.25%952K
-Change in receivables
-99.15%85K
--0
--0
--0
-96.28%85K
504.51%9.96M
381.29%4.5M
-34.08%1.12M
-74.23%2.05M
121.69%2.29M
-Change in prepaid assets
255.27%4.53M
113.53%390K
1,466.56%4.09M
39.95%-472K
-49.43%530K
-13,804.76%-2.92M
-234.22%-2.88M
74.11%-299K
27.49%-786K
1,397.14%1.05M
-Change in payables and accrued expense
-7,187.41%-10.42M
91.16%-182K
-40.49%1.33M
-161.49%-479K
-904.80%-11.09M
-103.59%-143K
-615.79%-2.06M
-3.36%2.24M
-46.28%779K
-493.55%-1.1M
-Change in other current liabilities
-979.46%-13.61M
-3,773.77%-12.55M
-13.21%-360K
-13.46%-354K
-13.03%-347K
-49.23%-1.26M
-62.00%-324K
-68.25%-318K
31.13%-312K
-10,133.33%-307K
-Change in other working capital
-112.09%-64.86M
--0
--0
--0
-6,579.92%-64.86M
-288.52%-30.58M
-0.08%-1.27M
-5.20%-1.31M
-1,508.03%-27.03M
-104.76%-971K
Cash from discontinued investing activities
Operating cash flow
3.83%-50.47M
-59.25%-18M
75.86%-2.93M
22.53%-11.06M
-25.09%-18.49M
-7.67%-52.48M
27.10%-11.3M
28.46%-12.13M
-66.59%-14.27M
-91.45%-14.78M
Investing cash flow
Cash flow from continuing investing activities
-8.47%49.14M
0.76%19.54M
-98.78%122K
132.74%24.52M
-63.91%4.96M
679.02%53.69M
-3.56%19.4M
-33.85%10.03M
124.29%10.53M
-8.39%13.74M
Net PPE purchase and sale
80.00%-7K
--0
--0
-109.21%-7K
--0
92.69%-35K
86.60%-41K
93.86%-7K
249.02%76K
-687.50%-63K
Net investment purchase and sale
-8.52%49.15M
0.55%19.54M
-98.78%122K
134.50%24.52M
-64.07%4.96M
628.87%53.73M
-4.80%19.44M
-34.30%10.03M
124.14%10.46M
-8.02%13.8M
Cash from discontinued investing activities
Investing cash flow
-8.47%49.14M
0.76%19.54M
-98.78%122K
132.74%24.52M
-63.91%4.96M
679.02%53.69M
-3.56%19.4M
-33.85%10.03M
124.29%10.53M
-8.39%13.74M
Financing cash flow
Cash flow from continuing financing activities
-29,570.00%-11.87M
-208K
0
-11.66M
0
-100.08%-40K
0
0
0
79.38%-40K
Cash dividends paid
---11.66M
--0
--0
----
----
--0
--0
--0
----
----
Net other financing activities
-420.00%-208K
----
----
----
----
98.96%-40K
--0
--0
--0
79.38%-40K
Cash from discontinued financing activities
Financing cash flow
-29,570.00%-11.87M
---208K
--0
---11.66M
--0
-100.08%-40K
--0
--0
--0
79.38%-40K
Net cash flow
Beginning cash position
7.41%16.91M
-73.13%2.37M
-52.61%5.17M
-76.99%3.37M
7.41%16.91M
84.24%15.74M
-20.70%8.81M
-13.02%10.92M
-6.20%14.65M
84.24%15.74M
Current changes in cash
-1,232.16%-13.2M
-83.48%1.34M
-33.30%-2.81M
148.23%1.8M
-1,145.08%-13.53M
-83.80%1.17M
74.89%8.09M
-46.28%-2.11M
-21.69%-3.74M
-115.36%-1.09M
End cash Position
-78.08%3.71M
-78.08%3.71M
-73.13%2.37M
-52.61%5.17M
-76.99%3.37M
7.41%16.91M
7.41%16.91M
-20.70%8.81M
-13.02%10.92M
-6.20%14.65M
Free cash flow
3.88%-50.48M
-58.76%-18M
75.86%-2.93M
22.14%-11.06M
-24.56%-18.49M
-6.69%-52.52M
28.29%-11.34M
28.94%-12.13M
-64.87%-14.21M
-92.07%-14.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.83%-50.47M-59.25%-18M75.86%-2.93M22.53%-11.06M-25.09%-18.49M-7.67%-52.48M27.10%-11.3M28.46%-12.13M-66.59%-14.27M-91.45%-14.78M
Net income from continuing operations 155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M5.06%-16.62M
Operating gains losses 102.90%32K----------------94.68%-1.1M--0103.91%500K91.10%-486K56.82%-1.12M
Depreciation and amortization -0.78%383K27.55%125K-11.34%86K-7.61%85K-12.12%87K18.40%386K15.29%98K8.99%97K22.67%92K28.57%99K
Other non cash items 70.26%2.43M254.37%1.3M7.22%386K6.78%378K6.59%372K57.21%1.43M34.07%366K92.51%360K--354K--349K
Change In working capital -237.82%-84.28M-506.24%-12.34M253.04%5.06M94.84%-1.31M-8,050.32%-75.69M-247.83%-24.95M-294.57%-2.04M0.21%1.43M-507.93%-25.3M-90.25%952K
-Change in receivables -99.15%85K--0--0--0-96.28%85K504.51%9.96M381.29%4.5M-34.08%1.12M-74.23%2.05M121.69%2.29M
-Change in prepaid assets 255.27%4.53M113.53%390K1,466.56%4.09M39.95%-472K-49.43%530K-13,804.76%-2.92M-234.22%-2.88M74.11%-299K27.49%-786K1,397.14%1.05M
-Change in payables and accrued expense -7,187.41%-10.42M91.16%-182K-40.49%1.33M-161.49%-479K-904.80%-11.09M-103.59%-143K-615.79%-2.06M-3.36%2.24M-46.28%779K-493.55%-1.1M
-Change in other current liabilities -979.46%-13.61M-3,773.77%-12.55M-13.21%-360K-13.46%-354K-13.03%-347K-49.23%-1.26M-62.00%-324K-68.25%-318K31.13%-312K-10,133.33%-307K
-Change in other working capital -112.09%-64.86M--0--0--0-6,579.92%-64.86M-288.52%-30.58M-0.08%-1.27M-5.20%-1.31M-1,508.03%-27.03M-104.76%-971K
Cash from discontinued investing activities
Operating cash flow 3.83%-50.47M-59.25%-18M75.86%-2.93M22.53%-11.06M-25.09%-18.49M-7.67%-52.48M27.10%-11.3M28.46%-12.13M-66.59%-14.27M-91.45%-14.78M
Investing cash flow
Cash flow from continuing investing activities -8.47%49.14M0.76%19.54M-98.78%122K132.74%24.52M-63.91%4.96M679.02%53.69M-3.56%19.4M-33.85%10.03M124.29%10.53M-8.39%13.74M
Net PPE purchase and sale 80.00%-7K--0--0-109.21%-7K--092.69%-35K86.60%-41K93.86%-7K249.02%76K-687.50%-63K
Net investment purchase and sale -8.52%49.15M0.55%19.54M-98.78%122K134.50%24.52M-64.07%4.96M628.87%53.73M-4.80%19.44M-34.30%10.03M124.14%10.46M-8.02%13.8M
Cash from discontinued investing activities
Investing cash flow -8.47%49.14M0.76%19.54M-98.78%122K132.74%24.52M-63.91%4.96M679.02%53.69M-3.56%19.4M-33.85%10.03M124.29%10.53M-8.39%13.74M
Financing cash flow
Cash flow from continuing financing activities -29,570.00%-11.87M-208K0-11.66M0-100.08%-40K00079.38%-40K
Cash dividends paid ---11.66M--0--0----------0--0--0--------
Net other financing activities -420.00%-208K----------------98.96%-40K--0--0--079.38%-40K
Cash from discontinued financing activities
Financing cash flow -29,570.00%-11.87M---208K--0---11.66M--0-100.08%-40K--0--0--079.38%-40K
Net cash flow
Beginning cash position 7.41%16.91M-73.13%2.37M-52.61%5.17M-76.99%3.37M7.41%16.91M84.24%15.74M-20.70%8.81M-13.02%10.92M-6.20%14.65M84.24%15.74M
Current changes in cash -1,232.16%-13.2M-83.48%1.34M-33.30%-2.81M148.23%1.8M-1,145.08%-13.53M-83.80%1.17M74.89%8.09M-46.28%-2.11M-21.69%-3.74M-115.36%-1.09M
End cash Position -78.08%3.71M-78.08%3.71M-73.13%2.37M-52.61%5.17M-76.99%3.37M7.41%16.91M7.41%16.91M-20.70%8.81M-13.02%10.92M-6.20%14.65M
Free cash flow 3.88%-50.48M-58.76%-18M75.86%-2.93M22.14%-11.06M-24.56%-18.49M-6.69%-52.52M28.29%-11.34M28.94%-12.13M-64.87%-14.21M-92.07%-14.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data